Global Etridiazole Market Growth 2025-2031

Publication ID:

LPI06259470

Publication Date:

June 26, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Organic Farming [2]

Agriculture [3]

Industry & Manufacturing [4]

Description:

The global Etridiazole market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Etridiazole is a fungicide and pesticide used for prevention of pythium ultimum on cotton plants. It is also used for seed treatment of various crops, in cotton cultivation during planting stage and non-bearing coffee and citrus fruits by horticultural nurseries. It has the chemical formula C5H5Cl3N2OS and the IUPAC name 5-ethoxy-3-(trichloromethyl)-1,2,4-thiadiazole
United States market for Etridiazole is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Etridiazole is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Etridiazole is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Etridiazole players cover BASF, Bayer, Syngenta, FMC Corporation, Nufarm, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淓tridiazole Industry Forecast鈥� looks at past sales and reviews total world Etridiazole sales in 2024, providing a comprehensive analysis by region and market sector of projected Etridiazole sales for 2025 through 2031. With Etridiazole sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Etridiazole industry.
This Insight Report provides a comprehensive analysis of the global Etridiazole landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Etridiazole portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Etridiazole market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Etridiazole and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Etridiazole.
This report presents a comprehensive overview, market shares, and growth opportunities of Etridiazole market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Emulsifiable Concentrate
Wettable Powder
Segmentation by Application:
Seed Treatment
Soil Irrigation
Deworming and Sterilization
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
BASF
Bayer
Syngenta
FMC Corporation
Nufarm
Yingde Greatchem Chemicals
Key Questions Addressed in this Report
What is the 10-year outlook for the global Etridiazole market?
What factors are driving Etridiazole market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Etridiazole market opportunities vary by end market size?
How does Etridiazole break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Etridiazole Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Etridiazole by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Etridiazole by Country/Region, 2020, 2024 & 2031
2.2 Etridiazole Segment by Type
2.2.1 Emulsifiable Concentrate
2.2.2 Wettable Powder
2.3 Etridiazole Sales by Type
2.3.1 Global Etridiazole Sales Market Share by Type (2020-2025)
2.3.2 Global Etridiazole Revenue and Market Share by Type (2020-2025)
2.3.3 Global Etridiazole Sale Price by Type (2020-2025)
2.4 Etridiazole Segment by Application
2.4.1 Seed Treatment
2.4.2 Soil Irrigation
2.4.3 Deworming and Sterilization
2.5 Etridiazole Sales by Application
2.5.1 Global Etridiazole Sale Market Share by Application (2020-2025)
2.5.2 Global Etridiazole Revenue and Market Share by Application (2020-2025)
2.5.3 Global Etridiazole Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Etridiazole Breakdown Data by Company
3.1.1 Global Etridiazole Annual Sales by Company (2020-2025)
3.1.2 Global Etridiazole Sales Market Share by Company (2020-2025)
3.2 Global Etridiazole Annual Revenue by Company (2020-2025)
3.2.1 Global Etridiazole Revenue by Company (2020-2025)
3.2.2 Global Etridiazole Revenue Market Share by Company (2020-2025)
3.3 Global Etridiazole Sale Price by Company
3.4 Key Manufacturers Etridiazole Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Etridiazole Product Location Distribution
3.4.2 Players Etridiazole Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Etridiazole by Geographic Region
4.1 World Historic Etridiazole Market Size by Geographic Region (2020-2025)
4.1.1 Global Etridiazole Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Etridiazole Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Etridiazole Market Size by Country/Region (2020-2025)
4.2.1 Global Etridiazole Annual Sales by Country/Region (2020-2025)
4.2.2 Global Etridiazole Annual Revenue by Country/Region (2020-2025)
4.3 Americas Etridiazole Sales Growth
4.4 APAC Etridiazole Sales Growth
4.5 Europe Etridiazole Sales Growth
4.6 Middle East & Africa Etridiazole Sales Growth
5 Americas
5.1 Americas Etridiazole Sales by Country
5.1.1 Americas Etridiazole Sales by Country (2020-2025)
5.1.2 Americas Etridiazole Revenue by Country (2020-2025)
5.2 Americas Etridiazole Sales by Type (2020-2025)
5.3 Americas Etridiazole Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Etridiazole Sales by Region
6.1.1 APAC Etridiazole Sales by Region (2020-2025)
6.1.2 APAC Etridiazole Revenue by Region (2020-2025)
6.2 APAC Etridiazole Sales by Type (2020-2025)
6.3 APAC Etridiazole Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Etridiazole by Country
7.1.1 Europe Etridiazole Sales by Country (2020-2025)
7.1.2 Europe Etridiazole Revenue by Country (2020-2025)
7.2 Europe Etridiazole Sales by Type (2020-2025)
7.3 Europe Etridiazole Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Etridiazole by Country
8.1.1 Middle East & Africa Etridiazole Sales by Country (2020-2025)
8.1.2 Middle East & Africa Etridiazole Revenue by Country (2020-2025)
8.2 Middle East & Africa Etridiazole Sales by Type (2020-2025)
8.3 Middle East & Africa Etridiazole Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Etridiazole
10.3 Manufacturing Process Analysis of Etridiazole
10.4 Industry Chain Structure of Etridiazole
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Etridiazole Distributors
11.3 Etridiazole Customer
12 World Forecast Review for Etridiazole by Geographic Region
12.1 Global Etridiazole Market Size Forecast by Region
12.1.1 Global Etridiazole Forecast by Region (2026-2031)
12.1.2 Global Etridiazole Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Etridiazole Forecast by Type (2026-2031)
12.7 Global Etridiazole Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 BASF
13.1.1 BASF Company Information
13.1.2 BASF Etridiazole Product Portfolios and Specifications
13.1.3 BASF Etridiazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 BASF Main Business Overview
13.1.5 BASF Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer Etridiazole Product Portfolios and Specifications
13.2.3 Bayer Etridiazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 Syngenta
13.3.1 Syngenta Company Information
13.3.2 Syngenta Etridiazole Product Portfolios and Specifications
13.3.3 Syngenta Etridiazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Syngenta Main Business Overview
13.3.5 Syngenta Latest Developments
13.4 FMC Corporation
13.4.1 FMC Corporation Company Information
13.4.2 FMC Corporation Etridiazole Product Portfolios and Specifications
13.4.3 FMC Corporation Etridiazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 FMC Corporation Main Business Overview
13.4.5 FMC Corporation Latest Developments
13.5 Nufarm
13.5.1 Nufarm Company Information
13.5.2 Nufarm Etridiazole Product Portfolios and Specifications
13.5.3 Nufarm Etridiazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Nufarm Main Business Overview
13.5.5 Nufarm Latest Developments
13.6 Yingde Greatchem Chemicals
13.6.1 Yingde Greatchem Chemicals Company Information
13.6.2 Yingde Greatchem Chemicals Etridiazole Product Portfolios and Specifications
13.6.3 Yingde Greatchem Chemicals Etridiazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Yingde Greatchem Chemicals Main Business Overview
13.6.5 Yingde Greatchem Chemicals Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂